The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery Banding
Authors:
- 29 September 2022
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 38 (1) , 57-68
Abstract
Background Sodium glucose linked transporter 2 (SGLT2) inhibition not only reduces morbidity and mortality in patients with diagnosed heart failure but also prevents the development of heart failure hospitalization in those at risk. While studies to date have focused on the role of SGLT2 inhibition in left ventricular failure, whether this drug class is efficacious in the treatment and prevention of right heart failure has not been explored. Hypothesis We hypothesized that SGLT2 inhibition would reduce the structural, functional, and molecular responses to pressure overload of the right ventricle. Methods Thirteen-week-old Fischer F344 rats underwent pulmonary artery banding (PAB) or sham surgery prior to being randomized to receive either the SGLT2 inhibitor: dapagliflozin (0.5 mg/kg/day) or vehicle by oral gavage. After 6 weeks of treatment, animals underwent transthoracic echocardiography and invasive hemodynamic studies. Animals were then terminated, and their hearts harvested for structural and molecular analyses. Results PAB induced features consistent with a compensatory response to increased right ventricular (RV) afterload with elevated mass, end systolic pressure, collagen content, and alteration in calcium handling protein expression (all p < 0.05 when compared to sham + vehicle). Dapagliflozin reduced RV mass, including both wet and dry weight as well as normalizing the protein expression of SERCA 2A, phospho-AMPK and LC3I/II ratio expression (all p < 0.05). Significance Dapagliflozin reduces the structural, functional, and molecular manifestations of right ventricular pressure overload. Whether amelioration of these early changes in the RV may ultimately lead to a reduction in RV failure remains to be determined.Keywords
All Related Versions
Funding Information
- Canada Excellence Research Chairs, Government of Canada
This publication has 36 references indexed in Scilit:
- The Right Ventricle in Pulmonary Arterial HypertensionCirculation Research, 2014
- Right Versus Left Ventricular FailureCirculation, 2014
- Right Heart Adaptation to Pulmonary Arterial HypertensionJACC, 2013
- Pathological Ventricular RemodelingCirculation, 2013
- Pathological Ventricular RemodelingCirculation, 2013
- The Failing Right Ventricle in Congenital Heart DiseaseCanadian Journal of Cardiology, 2013
- Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admissionEuropean Heart Journal, 2013
- Right Ventricle: Wrong Targets?Circulation, 2013
- Left Ventricular Failure Produces Profound Lung Remodeling and Pulmonary Hypertension in MiceHypertension, 2012
- MRI based non-invasive detection of cardiomyocyte hypertrophy and cell-volume changesJournal of Cardiovascular Magnetic Resonance, 2012